Abstract: Early diagnosis and differentiation of breast tuberculosis is difficult, and it is very easy to misdiagnose and delay the disease. In the early stage of the disease, traditional Chinese medicine can be used in combination, and in the stable stage of the disease, a reasonable choice of surgical treatment can shorten the course of the disease. This also reveals the important value of integrated Chinese and Western medicine treatment in the clinical treatment of this type of patient.
Introduction: The "Diagnostic Chameleon"
Breast tuberculosis (BTB) is a rare clinical entity, accounting for less than 3% of breast diseases in endemic areas. Because it lacks highly specific symptoms, it frequently masquerades as breast cancer or inflammatory conditions like granulomatous mastitis (GM). This "diagnostic chameleon" often leads to significant delays in treatment, as standard bacterial cultures frequently yield false negatives.
This case report details a rare "double whammy": an elderly patient presenting with BTB combined with GM. The authors demonstrate how an integrative strategy—combining Traditional Chinese Medicine (TCM) for early stabilization with Western surgical intervention and molecular diagnostics—can achieve a successful prognosis.
The Integrative Treatment Strategy
The management of this 71-year-old patient followed a structured three-phase protocol designed to bridge the gaps between traditional and modern medical practices.
Phase 1: TCM Stabilization
Initially, the patient was treated with an internal TCM decoction (including Radix Angelicae Sinensis and Radix Astragali) and topical ointments. The goal was to "subdue swelling and dissipate nodules," effectively cooling down the inflammatory tissue to prepare for a more precise surgical intervention.
Phase 2: Surgical Intervention
Once the local infection was localized and the mass reduced, a surgical excision was performed. Surgeons identified characteristic "caseous" (cheese-like) necrotic material and sinus tracts extending deep toward the pectoralis major muscle.
Phase 3: Definitive Diagnosis and Pharmacotherapy
Post-operative molecular testing (TB-DNA PCR) provided the definitive evidence of Mycobacterium tuberculosis. This allowed for the initiation of a standard 6-month quadruple-drug regimen: Isoniazid, Rifampicin, Ethambutol, and Pyrazinamide.
Clinical and Imaging Results
The integrative approach yielded significant quantitative and qualitative improvements:
- Mass Reduction: Under the 5-week TCM regimen, the palpable breast mass reduced from approximately 4x3 cm to 2x2 cm.
- Imaging Confirmation: Initial ultrasound and CT imaging revealed a complex, irregular mass with internal sub-mammary involvement.
- Long-term Outcome: At the six-month follow-up, ultrasound showed no remaining lesions, and the surgical site had healed completely.
Key Insights and Discussion
This case highlights several critical clinical lessons:
- GM as a Red Flag: In elderly patients, the presentation of granulomatous mastitis should prompt an investigation for underlying tuberculosis, particularly if there is a history of prior lymphatic TB.
- TCM as a Pre-Surgical Tool: TCM should not necessarily be viewed as a standalone cure but as a valuable tool to reduce the scope of abscesses, making subsequent surgery more effective.
- Molecular Necessity: Traditional acid-fast staining is often unreliable for BTB. Molecular pathology (PCR) is essential for a definitive diagnosis and the timely start of anti-TB therapy.
Conclusion
While limited by its single-patient scope, this case suggests that a "TCM-first, Surgery-second" protocol can be highly effective for rare inflammatory breast diseases. Future multi-center studies are needed to validate this integrated Chinese and Western medicine approach on a broader scale.
Summary updated